2023 Q2 Form 10-Q Financial Statement

#000165495423006316 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $11.21M $10.77M $8.252M
YoY Change 30.59% 30.52% -4.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $266.9K $276.7K $285.2K
YoY Change -6.29% -2.99% 9.69%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.946M $2.247M $693.3K
YoY Change 292.58% 224.07% -18.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.962M $4.116M $2.929M
YoY Change 7.1% 40.54% -20.9%
Income Tax $765.9K $777.2K $523.0K
% Of Pretax Income 19.33% 18.88% 17.86%
Net Earnings $3.196M $3.339M $2.406M
YoY Change 5.8% 38.79% -20.5%
Net Earnings / Revenue 28.5% 31.0% 29.15%
Basic Earnings Per Share $0.58 $0.61 $0.44
Diluted Earnings Per Share $0.58 $0.61 $446.9K
COMMON SHARES
Basic Shares Outstanding 5.456M shares 5.438M shares 5.383M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $19.34M $37.65M $84.45M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $12.65M $12.87M $13.50M
YoY Change -4.63% -4.66% 7.52%
Goodwill $11.57M $11.57M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.032B $1.031B $1.005B
YoY Change 3.24% 2.52% 7.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.851M $5.874M $2.898M
YoY Change 100.83% 102.73% 7.32%
Accrued Expenses $551.0K $605.0K $812.0K
YoY Change -36.23% -25.49% -18.8%
Deferred Revenue
YoY Change
Short-Term Debt $35.13M $38.06M $28.74M
YoY Change 12.48% 32.4% -10.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.54M $44.54M $3.710M
YoY Change 894.9% 1100.59% 0.26%
LONG-TERM LIABILITIES
Long-Term Debt $16.42M $16.48M $16.69M
YoY Change -1.92% -1.29% 9.1%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $16.42M $16.48M $16.69M
YoY Change -1.92% -1.29% 9.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.54M $44.54M $3.710M
Total Long-Term Liabilities $16.42M $16.48M $16.69M
Total Liabilities $951.3M $950.9M $927.7M
YoY Change 2.8% 2.49% 7.95%
SHAREHOLDERS EQUITY
Retained Earnings $49.89M $47.98M
YoY Change 22.62%
Common Stock $14.21M $14.16M
YoY Change 1.21%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.623M $2.623M
YoY Change 0.0%
Treasury Stock Shares 210.1K shares 210.1K shares
Shareholders Equity $80.52M $79.68M $77.44M
YoY Change
Total Liabilities & Shareholders Equity $1.032B $1.031B $1.005B
YoY Change 3.24% 2.52% 7.22%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $3.196M $3.339M $2.406M
YoY Change 5.8% 38.79% -20.5%
Depreciation, Depletion And Amortization $266.9K $276.7K $285.2K
YoY Change -6.29% -2.99% 9.69%
Cash From Operating Activities $2.137M $3.539M $2.708M
YoY Change -39.84% 30.66% -53.92%
INVESTING ACTIVITIES
Capital Expenditures $95.15K $159.0K -$70.69K
YoY Change -197.68% -324.88% -97.34%
Acquisitions
YoY Change
Other Investing Activities -$18.97M -$6.413M -$21.61M
YoY Change 12.42% -70.33% -50.06%
Cash From Investing Activities -$19.07M -$6.572M -$21.68M
YoY Change 12.34% -69.69% -52.8%
FINANCING ACTIVITIES
Cash Dividend Paid $932.9K $900.9K
YoY Change 3.55%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -1.374M -$30.46M -$6.931M
YoY Change -65.33% 339.49% -138.07%
NET CHANGE
Cash From Operating Activities 2.137M $3.539M $2.708M
Cash From Investing Activities -19.07M -$6.572M -$21.68M
Cash From Financing Activities -1.374M -$30.46M -$6.931M
Net Change In Cash -18.30M -$33.50M -$25.91M
YoY Change 5.28% 29.29% 18.53%
FREE CASH FLOW
Cash From Operating Activities $2.137M $3.539M $2.708M
Capital Expenditures $95.15K $159.0K -$70.69K
Free Cash Flow $2.041M $3.380M $2.779M
YoY Change -44.06% 21.62% -67.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
210101 shares
CY2023Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
30653 usd
CY2022Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
16460 usd
CY2023Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
329411 usd
CY2022Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
80660 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10770225 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8251546 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1844747 usd
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
551959 usd
CY2023Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
24520 usd
CY2022Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
21965 usd
CY2023Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
132128 usd
CY2022Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
21040 usd
CY2022Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
98352 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2246860 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
693316 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8523365 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7558230 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8236839 usd
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6695730 usd
CY2023Q1 cmtv Service Fee Income
ServiceFeeIncome
880288 usd
CY2023Q1 us-gaap Interest And Fee Income Loans Held For Sale Mortgages
InterestAndFeeIncomeLoansHeldForSaleMortgages
107535 usd
CY2022Q1 us-gaap Interest And Fee Income Loans Held For Sale Mortgages
InterestAndFeeIncomeLoansHeldForSaleMortgages
203842 usd
CY2023Q1 us-gaap Interest And Fee Income Other Loans
InterestAndFeeIncomeOtherLoans
428572 usd
CY2022Q1 us-gaap Interest And Fee Income Other Loans
InterestAndFeeIncomeOtherLoans
271260 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
1758777 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
777153 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
523029 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5444040 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000718413
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 cmtv Time Deposits Over
TimeDepositsOver
250000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
15 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
15 shares
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
100000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
210101 shares
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
58664 usd
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
0 usd
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
195082 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-16435
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Community Bancorp./VT
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VT
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0284070
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4811 US Route 5
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Derby
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
05829
CY2023Q1 dei City Area Code
CityAreaCode
802
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
334-7915
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15 shares
CY2023Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
100000 usd
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5455805 shares
CY2023Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
192679330 usd
CY2022Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
192918109 usd
CY2023Q1 cmtv Loans Gross
LoansGross
758586712 usd
CY2022Q4 cmtv Loans Gross
LoansGross
748548608 usd
CY2023Q1 cmtv Allowance For Credit Losses For Loan
allowanceForCreditLossesForLoan
9256170 usd
CY2022Q4 cmtv Allowance For Credit Losses For Loan
allowanceForCreditLossesForLoan
8709225 usd
CY2023Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
509611 usd
CY2022Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
493275 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
749840153 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
740332658 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12874462 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13042468 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
3111173 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
3214332 usd
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5173002 usd
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5153387 usd
CY2023Q1 us-gaap Goodwill
Goodwill
11574269 usd
CY2022Q4 us-gaap Goodwill
Goodwill
11574269 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
16205454 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
17244846 usd
CY2023Q1 us-gaap Assets
Assets
1030539393 usd
CY2022Q4 us-gaap Assets
Assets
1056032147 usd
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
200311094 usd
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
216093534 usd
CY2023Q1 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
279977413 usd
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
294050079 usd
CY2023Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
132554229 usd
CY2022Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
140117086 usd
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
170452633 usd
CY2022Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
171072921 usd
CY2023Q1 cmtv Time Deposits Over
TimeDepositsOver
250000 usd
CY2023Q1 cmtv Time Deposits And Over
TimeDepositsAndOver
16737914 usd
CY2022Q4 cmtv Time Deposits And Over
TimeDepositsAndOver
15632058 usd
CY2023Q1 cmtv Other Time Deposits
OtherTimeDeposits
88511815 usd
CY2022Q4 cmtv Other Time Deposits
OtherTimeDeposits
86006601 usd
CY2023Q1 us-gaap Deposits
Deposits
888545098 usd
CY2022Q4 us-gaap Deposits
Deposits
922972279 usd
CY2023Q1 cmtv Federal Funds Purchased And Other Borrowed Funds
FederalFundsPurchasedAndOtherBorrowedFunds
1300000 usd
CY2022Q4 cmtv Federal Funds Purchased And Other Borrowed Funds
FederalFundsPurchasedAndOtherBorrowedFunds
1300000 usd
CY2023Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
38058036 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
33077829 usd
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
12887000 usd
CY2022Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
12887000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
10069472 usd
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
10618676 usd
CY2023Q1 us-gaap Liabilities
Liabilities
950859606 usd
CY2022Q4 us-gaap Liabilities
Liabilities
980855784 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
1500000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5665187 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5647710 shares
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9376025 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7487200 usd
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
943478 usd
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
656277 usd
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
90658 usd
CY2022Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
10949 usd
CY2023Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
245465 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
286526 usd
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
862500 usd
CY2022Q1 cmtv Service Fee Income
ServiceFeeIncome
862887 usd
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
342382 usd
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
348440 usd
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
1686429 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
2288760 usd
CY2022Q1 us-gaap Salaries And Wages
SalariesAndWages
2040000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
754270 usd
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
772052 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
770986 usd
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
753364 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2065686 usd
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1888172 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
5879702 usd
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
5453588 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4115914 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2928571 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5382678 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
3383314 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-11069161 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
710496 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2324524 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2672818 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8744637 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6011579 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6339095 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
75176363 usd
CY2023Q1 cmtv Cumulative Change In Accounting Principle
CumulativeChangeInAccountingPrinciple
-549113 usd
CY2023Q1 cmtv Balance As Adjusted For Accounting Principal
BalanceAsAdjustedForAccountingPrincipal
74627250 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
319877 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1250794 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
28125 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
2672818 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
79679787 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
84760268 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
272683 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1236880 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
12188 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-8744637 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
77444788 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
276656 usd
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
285202 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
286526 usd
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
862500 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-68835 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
47344 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
29331 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
102945 usd
CY2023Q1 cmtv Income From Cfs Partners
IncomeFromCfsPartners
252051 usd
CY2022Q1 cmtv Income From Cfs Partners
IncomeFromCfsPartners
225870 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
66815 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
186967 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
1637381 usd
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
4725711 usd
CY2023Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
1608050 usd
CY2022Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
4529766 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
778860 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
408593 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-103159 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
318578 usd
CY2023Q1 us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
23370 usd
CY2022Q1 us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
-2374 usd
CY2023Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
50321 usd
CY2022Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
49669 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-53751 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-51283 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
72609 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
173852 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-19615 usd
CY2022Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-20060 usd
CY2023Q1 cmtv Amortization Of Limited Partnership
AmortizationOfLimitedPartnership
67128 usd
CY2022Q1 cmtv Amortization Of Limited Partnership
AmortizationOfLimitedPartnership
67092 usd
CY2023Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
16336 usd
CY2022Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
312318 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2485 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1332 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1040367 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-567062 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
73186 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-24896 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3538733 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2708284 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3555278 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4434388 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
19103623 usd
CY2023Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
67800 usd
CY2022Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
43500 usd
CY2023Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
92600 usd
CY2022Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
10074935 usd
CY2022Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
6998537 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
158971 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70686 usd
CY2023Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
132860 usd
CY2022Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
11780 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6571568 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21683178 usd
CY2023Q1 us-gaap Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
29855106 usd
CY2022Q1 us-gaap Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
12916068 usd
CY2023Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
-8183145 usd
CY2022Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
10606091 usd
CY2023Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
3611070 usd
CY2022Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
210469 usd
CY2023Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
4980207 usd
CY2022Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-3865864 usd
CY2023Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
54493 usd
CY2022Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
52807 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
28125 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12188 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
932901 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
900893 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30462493 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6931260 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-33495328 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-25906154 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71140328 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110358926 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37645000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84452772 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2249345 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
694648 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
3383314 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-11069161 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1250794 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1236880 usd
CY2023Q1 cmtv Decrease Increase In Dividends Payable Attributable To Dividends Declared
DecreaseIncreaseInDividendsPayableAttributableToDividendsDeclared
1984 usd
CY2022Q1 cmtv Decrease Increase In Dividends Payable Attributable To Dividends Declared
DecreaseIncreaseInDividendsPayableAttributableToDividendsDeclared
-63304 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
319877 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
272683 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
932901 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
900893 usd
CY2023Q1 cmtv Reduction To Retained Earnings
ReductionToRetainedEarnings
549113 usd
CY2023Q1 cmtv Corresponding Adjustment On Loans
CorrespondingAdjustmentOnLoans
243376 usd
CY2023Q1 cmtv Adjustment In Other Liabilities
AdjustmentInOtherLiabilities
451704 usd
CY2023Q1 cmtv Deferred Tax Assets
DeferredTaxAssets
145967 usd
CY2022Q4 cmtv Loans Receivable Municipal
LoansReceivableMunicipal
34633055 usd
CY2022Q4 cmtv Composition Of Municipal
CompositionOfMunicipal
0.0463 pure
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
28125 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
12188 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3310636 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2393354 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5444040 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5382678 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
215457811 usd
CY2023Q1 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
209173 usd
CY2023Q1 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
22987654 usd
CY2023Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
192679330 usd
CY2022Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
219079904 usd
CY2022 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
110541 usd
CY2022 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
26272336 usd
CY2022Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
192918109 usd
CY2023Q1 cmtv Residential Real Estate First St Lien
ResidentialRealEstateFirstStLien
199033728 usd
CY2023Q1 cmtv Composition Of Residential Real Estate1 St Lien
CompositionOfResidentialRealEstate1StLien
0.2624 pure
CY2022Q4 cmtv Residential Real Estate First St Lien
ResidentialRealEstateFirstStLien
198743375 usd
CY2022Q4 cmtv Composition Of Residential Real Estate1 St Lien
CompositionOfResidentialRealEstate1StLien
0.2655 pure
CY2023Q1 cmtv Residential Real Estate Jr Lien
ResidentialRealEstateJrLien
31901495 usd
CY2023Q1 cmtv Composition Of Residential Real Estate Jr Lien
CompositionOfResidentialRealEstateJrLien
0.0421 pure
CY2022Q4 cmtv Residential Real Estate Jr Lien
ResidentialRealEstateJrLien
33756872 usd
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
20283227 usd
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
439580 usd
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
160642177 usd
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
22548074 usd
CY2023Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
221 integer
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
180925404 usd
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
22987654 usd
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
44811508 usd
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2267236 usd
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
141045975 usd
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
24005100 usd
CY2022Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
230 integer
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
185857483 usd
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
26272336 usd
CY2023Q1 cmtv Loans Receivable Commercial Industrial
LoansReceivableCommercialIndustrial
118898281 usd
CY2023Q1 cmtv Percentage Of Loans Receivable Commercial Industrial
PercentageOfLoansReceivableCommercialIndustrial
0.1567 pure
CY2022Q4 cmtv Loans Receivable Commercial Industrial
LoansReceivableCommercialIndustrial
112951873 usd
CY2022Q4 cmtv Percentage Of Loans Receivable Commercial Industrial
PercentageOfLoansReceivableCommercialIndustrial
0.1509 pure
CY2023Q1 cmtv Purchased Loans
PurchasedLoans
6697965 usd
CY2023Q1 cmtv Composition Of Purchased Loans
CompositionOfPurchasedLoans
0.0088 pure
CY2022Q4 cmtv Purchased Loans
PurchasedLoans
7530458 usd
CY2022Q4 cmtv Composition Of Purchased Loans
CompositionOfPurchasedLoans
0.01 pure
CY2023Q1 cmtv Loans Receivable Real Estate Commercial
LoansReceivableRealEstateCommercial
362136416 usd
CY2023Q1 cmtv Composition Of Commercial Real Estate
CompositionOfCommercialRealEstate
0.4774 pure
CY2022Q4 cmtv Loans Receivable Real Estate Commercial
LoansReceivableRealEstateCommercial
356892986 usd
CY2022Q4 cmtv Composition Of Commercial Real Estate
CompositionOfCommercialRealEstate
0.4768 pure
CY2023Q1 cmtv Loans Receivable Municipal
LoansReceivableMunicipal
36473847 usd
CY2023Q1 cmtv Composition Of Municipal
CompositionOfMunicipal
0.0481 pure
CY2022Q4 cmtv Composition Of Residential Real Estate Jr Lien
CompositionOfResidentialRealEstateJrLien
0.0451 pure
CY2023Q1 cmtv Loan And Lease Receivable Consumer
LoanAndLeaseReceivableConsumer
3444980 usd
CY2023Q1 cmtv Composition Of Consumer
CompositionOfConsumer
0.0045 pure
CY2022Q4 cmtv Loan And Lease Receivable Consumer
LoanAndLeaseReceivableConsumer
4039989 usd
CY2022Q4 cmtv Composition Of Consumer
CompositionOfConsumer
0.0054 pure
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
758586712 usd
CY2023Q1 cmtv Total Loan Percentage
TotalLoanPercentage
1 pure
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
748548608 usd
CY2022Q4 cmtv Total Loan Percentage
TotalLoanPercentage
1 pure
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
9256170 usd
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
8709225 usd
CY2023Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
509611 usd
CY2022Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
493275 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
749840153 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
740332658 usd
CY2023Q1 cmtv Provision For Credit Losses Loans
ProvisionForCreditLossesLoans
207540 usd
CY2022Q1 cmtv Provision For Credit Losses Loans
ProvisionForCreditLossesLoans
862500 usd
CY2023Q1 cmtv Provision For Credit Losses On Obs Credit Exposure
ProvisionForCreditLossesOnObsCreditExposure
78986 usd
CY2022Q1 cmtv Provision For Credit Losses On Obs Credit Exposure
ProvisionForCreditLossesOnObsCreditExposure
0 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
286526 usd
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
862500 usd
CY2022Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
8709225 usd
CY2023Q1 cmtv Allowanceforloanandleaselossesimpact Of Adopting
AllowanceforloanandleaselossesimpactOfAdopting
243376 usd
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-36831 usd
CY2023Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
132860 usd
CY2023Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
207540 usd
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
9256170 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
5403 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
9250767 usd
CY2023Q1 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
9256170 usd
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7964407 usd
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
750622305 usd
CY2023Q1 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
758586712 usd
CY2021Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7710256 usd
CY2022 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-807974 usd
CY2022 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
828943 usd
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
978000 usd
CY2022 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
8709225 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
108602 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
8600623 usd
CY2022Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
8709225 usd
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
10512387 usd
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
738036221 usd
CY2022 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
748548608 usd
CY2021Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7710256 usd
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-693888 usd
CY2022Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
11780 usd
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
862500 usd
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7890648 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
115614 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7775034 usd
CY2022Q1 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
7890648 usd
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7931944 usd
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
688361238 usd
CY2022Q1 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
696293182 usd
CY2023Q1 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
2796047 usd
CY2023Q1 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
4268769 usd
CY2023Q1 cmtv Notes Receivable Gross Financial Asset Past Due
NotesReceivableGrossFinancialAssetPastDue
7064816 usd
CY2023Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
751521896 usd
CY2023Q1 cmtv Loans Gross
LoansGross
758586712 usd
CY2022Q4 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
5631089 usd
CY2022Q4 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
1899792 usd
CY2022Q4 cmtv Notes Receivable Gross Financial Asset Past Due
NotesReceivableGrossFinancialAssetPastDue
7530881 usd
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
741017727 usd
CY2022Q4 cmtv Loans Gross
LoansGross
748548608 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
175981 usd
CY2023Q1 cmtv Non Accrual With An Acl
NonAccrualWithAnAcl
859759 usd
CY2023Q1 cmtv Non Accrual With No Acl
NonAccrualWithNoAcl
7620595 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
8480354 usd
CY2022Q4 cmtv Non Accrual With An Acl
NonAccrualWithAnAcl
730989 usd
CY2022Q4 cmtv Non Accrual With No Acl
NonAccrualWithNoAcl
7159031 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7890020 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
573084 usd
CY2023Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
195082 usd
CY2023Q1 cmtv Non Accrual Status Or Tdrs Regardless Of Amount
NonAccrualStatusOrTdrsRegardlessOfAmount
100000 usd
CY2023Q1 cmtv Business Assets Loan
BusinessAssetsLoan
1777018 usd
CY2023Q1 cmtv Commercial Real Estate Loan
CommercialRealEstateLoan
776329 usd
CY2023Q1 cmtv Residential Real Estate Loan
ResidentialRealEstateLoan
326922 usd
CY2023Q1 cmtv Collateral Dependent Loans
CollateralDependentLoans
2880268 usd
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
10523904 usd
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
12217992 usd
CY2023Q1 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
11517 usd
CY2022Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7970423 usd
CY2022Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
10227884 usd
CY2022Q1 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
38479 usd
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
8229830 usd
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
59063 usd
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
27487 usd
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
173180 usd
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
109922 usd
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
102034 usd
CY2023Q1 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
105698 usd
CY2023Q1 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
1794 usd
CY2023Q1 cmtv Total Loan
TotalLoan
758587 usd
CY2022Q4 cmtv Group A Acceptable Risk Loan
GroupAAcceptableRiskLoan
727442144 usd
CY2022Q4 cmtv Group B Management Involved Loans
GroupBManagementInvolvedLoans
9051060 usd
CY2022Q4 cmtv Group C Unacceptable Risk Loan
GroupCUnacceptableRiskLoan
12055404 usd
CY2022Q4 cmtv Loans Gross Amount
LoansGrossAmount
748548608 usd
CY2022Q4 cmtv Allowance Related To Tdr
AllowanceRelatedToTdr
106280 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
192679330 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
192918109 usd
CY2022Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
862593 usd
CY2021Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
897720 usd
CY2023Q1 us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
15814 usd
CY2022 us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
120629 usd
CY2023Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
39184 usd
CY2022 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
155756 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
0 usd
CY2022 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
0 usd
CY2023Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
839223 usd
CY2022Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
862593 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23

Files In Submission

Name View Source Status
cmtv-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cmtv-20230331_pre.xml Edgar Link unprocessable
0001654954-23-006316-index-headers.html Edgar Link pending
0001654954-23-006316-index.html Edgar Link pending
0001654954-23-006316.txt Edgar Link pending
0001654954-23-006316-xbrl.zip Edgar Link pending
cmtv-20230331.xsd Edgar Link pending
cmtv_10q.htm Edgar Link pending
cmtv_10qimg2.jpg Edgar Link pending
cmtv_ex311.htm Edgar Link pending
cmtv_ex312.htm Edgar Link pending
cmtv_ex321.htm Edgar Link pending
cmtv_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
cmtv-20230331_lab.xml Edgar Link unprocessable
cmtv-20230331_cal.xml Edgar Link unprocessable
cmtv_10q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending